AbbVie AndroGel Patent Suits Baseless, Pa. Judge Finds

By Matthew Guarnaccia (September 15, 2017, 10:18 PM EDT) -- A Pennsylvania federal judge on Friday granted a partial victory to the Federal Trade Commission in its lawsuit alleging drugmakers including AbbVie Inc. filed sham patent litigation against generic rivals over AbbVie's testosterone replacement treatment AndroGel, finding the suits to be without merit based on the patent's prosecution history....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!